glp 1 in obesity GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1-based therapies for diabetes, obesity

Some experts suggest an induction-maintenance model : initiating treatment with subcutaneous injections for rapid initial weight loss, followed by long-term oral maintenance

That gap is the opportunity

There are several overlapping reasons: Food stays in the stomach longer, which can extend fullness

A boxed warning, previously known as a black box warning, is the most serious warning from the Food and Drug Administration (FDA)

doi: 10.1172/JCI57256 50 WiciskiMSochaMMalinowskiBWdkiewiczEWalczakMGrskiKet al

Adverse events linked to GLP-1 medicines The most common side effects of GLP-1RAs are gastrointestinal, including nausea, diarrhea, constipation, and vomiting